BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 9111327)

  • 1. Induction of cell proliferation in quiescent NIH 3T3 cells by oncogenic c-Raf-1.
    Kerkhoff E; Rapp UR
    Mol Cell Biol; 1997 May; 17(5):2576-86. PubMed ID: 9111327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated Raf-1 causes growth arrest in human small cell lung cancer cells.
    Ravi RK; Weber E; McMahon M; Williams JR; Baylin S; Mal A; Harter ML; Dillehay LE; Claudio PP; Giordano A; Nelkin BD; Mabry M
    J Clin Invest; 1998 Jan; 101(1):153-9. PubMed ID: 9421477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-intensity Raf signals convert mitotic cell cycling into cellular growth.
    Kerkhoff E; Rapp UR
    Cancer Res; 1998 Apr; 58(8):1636-40. PubMed ID: 9563474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conditionally oncogenic forms of the A-Raf and B-Raf protein kinases display different biological and biochemical properties in NIH 3T3 cells.
    Pritchard CA; Samuels ML; Bosch E; McMahon M
    Mol Cell Biol; 1995 Nov; 15(11):6430-42. PubMed ID: 7565795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid phosphorylation of Ets-2 accompanies mitogen-activated protein kinase activation and the induction of heparin-binding epidermal growth factor gene expression by oncogenic Raf-1.
    McCarthy SA; Chen D; Yang BS; Garcia Ramirez JJ; Cherwinski H; Chen XR; Klagsbrun M; Hauser CA; Ostrowski MC; McMahon M
    Mol Cell Biol; 1997 May; 17(5):2401-12. PubMed ID: 9111309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1.
    Woods D; Parry D; Cherwinski H; Bosch E; Lees E; McMahon M
    Mol Cell Biol; 1997 Sep; 17(9):5598-611. PubMed ID: 9271435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1).
    Cheng M; Sexl V; Sherr CJ; Roussel MF
    Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1091-6. PubMed ID: 9448290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of platelet-derived growth factor- and epidermal growth factor-mediated mitogenesis and signaling in 3T3 cells expressing delta Raf-1:ER, an estradiol-regulated form of Raf-1.
    Samuels ML; McMahon M
    Mol Cell Biol; 1994 Dec; 14(12):7855-66. PubMed ID: 7969125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ras activity late in G1 phase required for p27kip1 downregulation, passage through the restriction point, and entry into S phase in growth factor-stimulated NIH 3T3 fibroblasts.
    Takuwa N; Takuwa Y
    Mol Cell Biol; 1997 Sep; 17(9):5348-58. PubMed ID: 9271412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic transformation of cells by a conditionally active form of the protein kinase Akt/PKB.
    Mirza AM; Kohn AD; Roth RA; McMahon M
    Cell Growth Differ; 2000 Jun; 11(6):279-92. PubMed ID: 10910095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid induction of heparin-binding epidermal growth factor/diphtheria toxin receptor expression by Raf and Ras oncogenes.
    McCarthy SA; Samuels ML; Pritchard CA; Abraham JA; McMahon M
    Genes Dev; 1995 Aug; 9(16):1953-64. PubMed ID: 7649477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential modulation of G1 cyclins and the Cdk inhibitor p27kip1 by platelet-derived growth factor and plasma factors in density-arrested fibroblasts.
    Winston J; Dong F; Pledger WJ
    J Biol Chem; 1996 May; 271(19):11253-60. PubMed ID: 8626675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway.
    Lavoie JN; L'Allemain G; Brunet A; Müller R; Pouysségur J
    J Biol Chem; 1996 Aug; 271(34):20608-16. PubMed ID: 8702807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations of critical amino acids affect the biological and biochemical properties of oncogenic A-Raf and Raf-1.
    Bosch E; Cherwinski H; Peterson D; McMahon M
    Oncogene; 1997 Aug; 15(9):1021-33. PubMed ID: 9285556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DeltaRaf-1:ER* bypasses the cyclic AMP block of extracellular signal-regulated kinase 1 and 2 activation but not CDK2 activation or cell cycle reentry.
    Balmanno K; Millar T; McMahon M; Cook SJ
    Mol Cell Biol; 2003 Dec; 23(24):9303-17. PubMed ID: 14645540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diverse effects of RacV12 on cell transformation by Raf: partial inhibition of morphological transformation versus deregulation of cell cycle control.
    Kerkhoff E; Leberfinger CB; Schmidt G; Aktories K; Rapp UR
    Biochim Biophys Acta; 2002 Apr; 1589(2):151-9. PubMed ID: 12007790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An anchorage-dependent signal distinct from p42/44 MAP kinase activation is required for cell cycle progression.
    Le Gall M; Grall D; Chambard JC; Pouysségur J; Van Obberghen-Schilling E
    Oncogene; 1998 Sep; 17(10):1271-7. PubMed ID: 9771970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic raf-1 induces the expression of non-histone chromosomal architectural protein HMGI-C via a p44/p42 mitogen-activated protein kinase-dependent pathway in salivary epithelial cells.
    Li D; Lin HH; McMahon M; Ma H; Ann DK
    J Biol Chem; 1997 Oct; 272(40):25062-70. PubMed ID: 9312114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complementation of defective colony-stimulating factor 1 receptor signaling and mitogenesis by Raf and v-Src.
    Aziz N; Cherwinski H; McMahon M
    Mol Cell Biol; 1999 Feb; 19(2):1101-15. PubMed ID: 9891045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential abilities of the Raf family of protein kinases to abrogate cytokine dependency and prevent apoptosis in murine hematopoietic cells by a MEK1-dependent mechanism.
    Hoyle PE; Moye PW; Steelman LS; Blalock WL; Franklin RA; Pearce M; Cherwinski H; Bosch E; McMahon M; McCubrey JA
    Leukemia; 2000 Apr; 14(4):642-56. PubMed ID: 10764150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.